Events › B2B Event
B2B Event
A virtual forum focused on the latest advancements in antibody-drug conjugate (ADC) bioconjugation, chemistry, linker technologies, and payloads to improve targeted cancer therapies.
Filter this event to your ICP.
Hundreds of exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Why people attend
To source new conjugation technologies, explore novel payloads, and find partners for ADC development and manufacturing to overcome stability and efficacy challenges.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
More B2B Event events
Past & future editions
More events in United Kingdom
Frequently asked questions